Andere Kunden interessierten sich auch für
![Management of Pancreatic Diseases, an Issue of Gastroenterology Clinics of North America]( "Management of Pancreatic Diseases, an Issue of Gastroenterology Clinics of North America")
Management of Pancreatic Diseases, an Issue of Gastroenterology Clinics of North America118,99 €![Nutritional Management of Gastrointestinal Diseases, an Issue of Gastroenterology Clinics of North America]( "Nutritional Management of Gastrointestinal Diseases, an Issue of Gastroenterology Clinics of North America")
Nutritional Management of Gastrointestinal Diseases, an Issue of Gastroenterology Clinics of North America118,99 €![Helicobacter Pylori Infection: Pathophysiology, Epidemiology and Management]( "Helicobacter Pylori Infection: Pathophysiology, Epidemiology and Management")
Helicobacter Pylori Infection: Pathophysiology, Epidemiology and Management137,99 €![Helicobacter Pylori in Human Diseases]( "Helicobacter Pylori in Human Diseases")
Helicobacter Pylori in Human Diseases148,99 €![Clinical Aspects of Helicobacter Pylori Infection]( "Clinical Aspects of Helicobacter Pylori Infection")
Clinical Aspects of Helicobacter Pylori Infection156,99 €![Neurologic Manifestations of Rheumatic Diseases, an Issue of Rheumatic Disease Clinics of North America]( "Neurologic Manifestations of Rheumatic Diseases, an Issue of Rheumatic Disease Clinics of North America")
Neurologic Manifestations of Rheumatic Diseases, an Issue of Rheumatic Disease Clinics of North America153,99 €![Diagnosis and Management of Chronic Liver Diseases, an Issue of Medical Clinics]( "Diagnosis and Management of Chronic Liver Diseases, an Issue of Medical Clinics")
Diagnosis and Management of Chronic Liver Diseases, an Issue of Medical Clinics118,99 €
Helicobacter pylori (H. pylori) infection is a worldwide disease with a significant morbidity and mortality; it is the leading cause of non-ulcer dyspepsia, peptic ulcers and gastric tumors, including low-grade mucosa-associated lymphoid tissue-lymphoma and adenocarcinoma. In addition, it has also been recognized that the interaction between H. pylori and non-steroidal, anti-inflammatory drugs is damaging to the gastroduodenal mucosa. H. pylori treatment still remains a challenge for physicians, since no current first-line therapy is able to cure the infection in all treated patients. This issue will serve to update gastroenterologists on current therapies, evaluation and management of disease progression, and the future of management of H. pylori infection.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.